KTE-C19 (anti-CD19 chimeric antigen receptor [CAR] T cell therapy) in pediatric and adolescent patients with relapsed/refractory acute lymphoblastic leukemia (R/R ALL): Preliminary Results of ZUMA-4

We present preliminary ZUMA-4 phase 1 results.

Source: Clinical Lymphoma, Myeloma and Leukemia - September 1, 2017 Category: Hematology Authors: Daniel W. Lee, Alan Wayne, Van Huynh, Rupert Handgretinger, Rob Pieters, Gerard Michel, Andre Baruchel, Tobias Feuchtinger, Yves Bertrand, Michelle Hemiston, Patrick Brown, John Rossi, Yizhou Jiang, Lynn Navale, Shanna Stout, Jeff Aycock, Armen Mardiros, Source Type: research